Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ITF2357 in Autoinflammatory Syndromes
NCT00442182Phase 2Unknown
- Sponsor
- Radboud University Medical Center
- Start
- Sep 2006
- Countries
- 1
01
Overview
A Phase 2 trial of givinostat in Autoinflammatory syndrome (AID), Hyperimmunoglobulinemia D with periodic fever syndrome (HIDS), TNF receptor-associated periodic syndrome (TRAPS), Schnitzler syndrome, sponsored by Radboud University Medical Center. Status: unknown.
02
Drugs
givinostat
03
Conditions
Autoinflammatory syndrome (AID)Hyperimmunoglobulinemia D with periodic fever syndrome (HIDS)TNF receptor-associated periodic syndrome (TRAPS)Schnitzler syndrome
Beyond the preview
Go deeper on NCT00442182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00442182.